ArticleFrontiers in immunology2025
IL-10 and IL-2R as combined predictors of intravenous immunoglobulin resistance in Kawasaki disease: a retrospective cohort study.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Intravenous immunoglobulin (IVIG) resistance in Kawasaki disease (KD) increases the risk of coronary artery lesions (CALs) and the need for additional therapies. Early identification remains a clinical challenge. This study evaluated the predictive value of interleukin (IL)-10 and IL-2 receptor (IL-2R) in detecting IVIG resistance. Methods: We retrospectively analyzed 529 children with KD treated at Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, from November 2019 to December 2024. Demographic and clinical characteristics, and laboratory data were compared between IVIG-responsive and IVIG-resistant groups. Multivariable logistic regression was used to identify independent predictors, and receiver operating characteristic (ROC) curves were used to assess predictive performance. Results: Among 529 patients, 88 (16.6%) were IVIG-resistant and 441 (83.3%) were IVIG-responsive. Compared with IVIG-responsive patients, IVIG-resistant patients had significantly higher levels of IL-10 and IL-2R. Both remained independent predictors after adjustment for confounders. ROC analysis demonstrated high predictive accuracy for IL-2R (AUC = 0.825) and limited predictive value for IL-10 (AUC = 0.767). The combination of IL-10 and IL-2R moderately improved predictive accuracy, achieving a better balance between sensitivity and specificity (AUC = 0.834, sensitivity 77.10%, specificity 79.56%). Subgroup analysis revealed that IL-2R had limited predictive value in infants younger than 12 months. However, in patients aged 12 months or older, both IL-10 and IL-2R were significant risk factors for IVIG resistance. Conclusion: IL-2R is an independent predictor of IVIG resistance in KD in the age group more than 12 months, and IL-10 serves as a complementary marker, and their combined use slightly enhances predictive utility across most age groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.